Guangliang Zhang

Dr. Guangliang Zhang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 July 2020 in Biofabrication
Verified
Journal Article
Closed access
LXLei Xu
Lei Xu
MVMathew Varkey
Mathew Varkey
AJAdam M Jorgensen
Adam M Jorgensen
JJJihui Ju
Jihui Ju
QJQianheng Jin
Qianheng Jin
AAAnthony Atala
Anthony Atala
Bioengineered artificial blood vessels have been a major area of interest over the last decade. Of particular interest are small diameter vessels, as surgical options are currently limited. This study aimed to fabricate a small diameter, heterogeneous bilayer blood vessel-like construct in a single step with gelatin methacryloyl (GelMA) bioink using a 3D micro-extrusion bioprinter on a solid platform. GelMA was supplemented with Hyaluronic acid (HA), glycerol and gelatin to form a GelMA bioink with good printability, mechanical strength, and biocompatibility. Two separate concentrations of GelMA bioink with unique pore sizes were selected to fabricate a heterogeneous bilayer. A higher concentration of GelMA bioink (6% w/v GelMA, 2% gelatin, 0.3% w/v HA, 10% v/v glycerol) was used to load human umbilical vein endothelial cells (HUVECs) and form an inner, endothelial tissue layer. A lower concentration of GelMA bioink (4% w/v GelMA, 4% gelatin, 0.3% w/v HA, 10% v/v glycerol) was used to load smooth muscle cells (SMCs) and form an outer, muscular tissue layer. Bioprinted blood vessel-like grafts were then assessed for mechanical properties with Instron mechanical testing, and suture-ability, and for biological properties including viability, proliferation, and histological analysis. The resulting 20 mm long, 4.0 mm diameter lumen heterogeneous bilayer blood vessel-like construct closely mimics a native blood vessel and maintains high cell viability and proliferation. Our results represent a novel strategy for small diameter blood vessel biofabrication.

16 December 2019 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
GZGuangliang Zhang
Guangliang Zhang
MVMathew Varkey
Mathew Varkey
ZWZhan Wang
Zhan Wang
BXBeibei Xie
Beibei Xie
RHRuixing Hou
Ruixing Hou
Anthony AtalaAnthony Atala
Anthony Atala

30 August 2023 in Acta Biomaterialia
Verified
Journal Article
Closed access
GZGuangliang Zhang
Guangliang Zhang
ZZZhiqiang Zhang
Zhiqiang Zhang
GCGaobiao Cao
Gaobiao Cao
QJQianheng Jin
Qianheng Jin
LXLei Xu
Lei Xu
RHRuixing Hou
Ruixing Hou

10 June 2021 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
GZGuangliang Zhang
Guangliang Zhang
ZWZhan Wang
Zhan Wang
FHFengxuan Han
Fengxuan Han
GJGuangzhe Jin
Guangzhe Jin
LXLei Xu
Lei Xu
RHRuixing Hou
Ruixing Hou

21 August 2022 in Stem Cells International
Verified
Journal Article
Open access
PDF file
ZLZhe Liu
Zhe Liu
YYYuan Yang
Yuan Yang
JJJihui Ju
Jihui Ju
GZGuangliang Zhang
Guangliang Zhang
PZPing Zhang
Ping Zhang
RHRuixing Hou
Ruixing Hou
Skin epidermal stem cells (EpSCs) play a critical role in wound healing and are ideal seed cells for skin tissue engineering. Exosomes from human adipose-derived stem cells (ADSC-Exos) promote human EpSC proliferation, but the underlying mechanism remains unclear. Here, we investigated the effect of miR-100-5p, one of the most abundant miRNAs in ADSC-Exos, on the proliferation of human EpSCs and explored the mechanisms involved. MTT and BrdU incorporation assays showed that miR-100-5p mimic transfection promoted EpSC proliferation in a time-dependent manner. Cell cycle analysis showed that miR-100-5p mimic transfection significantly decreased the percentage of cells in the G1 phase and increased the percentage of cells in the G2/M phase. Myotubularin-related protein 3 (MTMR3), a lipid phosphatase, was identified as a direct target of miR-100-5p. Knockdown of MTMR3 in EpSCs by RNA interference significantly enhanced cell proliferation, decreased the percentage of cells in the G1 phase and increased the percentage of cells in the S phase. Overexpression of MTMR3 reversed the proproliferative effect of miR-100-5p on EpSCs, indicating that miR-100-5p promoted EpSC proliferation by downregulating MTMR3. Mechanistic studies showed that transfection of EpSCs with miR-100-5p mimics elevated the intracellular PIP3 level, induced AKT and ERK phosphorylation, and upregulated cyclin D1, E1, and A2 expression, which could be attenuated by MTMR3 overexpression. Consistently, intradermal injection of ADSC-Exos or miR-100-5p-enriched ADSC-Exos into cultured human skin tissues significantly reduced MTMR3 expression and increased the thickness of the epidermis and the number of EpSCs in the basal layer of the epidermis. The aforementioned effect of miR-100-5p-enriched ADSC-Exos was stronger than that of ADSC-Exos and was reversed by MTMR3 overexpression. Collectively, our findings indicate that miR-100-5p promotes EpSC proliferation through MTMR3-mediated elevation of PIP3 and activation of AKT and ERK. miR-100-5p-enriched ADSC-Exos can be used to treat skin wound and expand EpSCs for generating epidermal autografts and engineered skin equivalents.

5 November 2023 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
ZZZhiqiang Zhang
Zhiqiang Zhang
CXChi Xu
Chi Xu
LXLei Xu
Lei Xu
JWJiaming Wan
Jiaming Wan
GCGaobiao Cao
Gaobiao Cao
GZGuangliang Zhang
Guangliang Zhang